Lexaria Bioscience (LEXX) Asset Utilization Ratio (2018 - 2026)
Lexaria Bioscience's (LEXX) Asset Utilization Ratio stood at 0.03 in fiscal Q3 2026 (quarter ended May 31, 2026), down 56.9% from 0.08 a year earlier and down 41.3% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Asset Utilization Ratio came in at 0.11, up 39.3% from FY2024.
- Annual Asset Utilization Ratio has increased for three straight fiscal years.
- Across earlier fiscal years, Asset Utilization Ratio came in at 0.08 in FY2024 (+87.5%), 0.04 in FY2023 (+71.2%), 0.02 in FY2022 (-73.0%) and 0.09 in FY2021 (-21.5%).
- The fiscal Q3 2026 figure is the lowest quarterly Asset Utilization Ratio since fiscal Q4 2022.
- On a year-over-year basis, Asset Utilization Ratio rose in four of the last eight quarters, with growth averaging 23.1%.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 256.2% in fiscal Q3 2023, against a decline of 79.7% in fiscal Q1 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 0.06 (Q2 2026), 0.10 (Q1 2026) and 0.13 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Lexaria Bioscience | 3.30 Mn | -12.35 Mn | - | 0.03 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.03 |
| Feb 28, 2026 | 0.06 |
| Nov 30, 2025 | 0.10 |
| Aug 31, 2025 | 0.13 |
| May 31, 2025 | 0.08 |
| Feb 28, 2025 | 0.06 |
| Nov 30, 2024 | 0.05 |
| Aug 31, 2024 | 0.05 |
| May 31, 2024 | 0.05 |
| Feb 29, 2024 | 0.08 |
| Nov 30, 2023 | 0.08 |
| Aug 31, 2023 | 0.05 |
| May 31, 2023 | 0.06 |
| Feb 28, 2023 | 0.06 |
| Nov 30, 2022 | 0.05 |
| Aug 31, 2022 | 0.03 |
| May 31, 2022 | 0.02 |
| Feb 28, 2022 | 0.02 |
| Nov 30, 2021 | 0.04 |
| Aug 31, 2021 | 0.06 |
API Access
Lexaria Bioscience Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();